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Purpose
• Develop and evaluate a mathematical model for delineating the passive and carrier 
mediated contributions to the absorption of some apical efflux substrates in Caco-2 
cell monolayers. 
• Evaluate the effect of concentration and binary combinations of substances, on 
permeation in terms of these two contributing factors, passive diffusion and active 
apical efflux.
• Integrate phase II metabolism and adsorption to the Transwell surface to the model.
• The objective was to overcome the limitations of the usually employed simple 
analysis that is based on calculation of the P
app
in apical to basal and basal to apical 
directions and the efflux ratio.
Methods
• Caco-2 cell monolayers grown in 6-well Transwells for 18 to 21 days  were used. 
• P-glycoprotein substrates Digoxin, Quinidine, Verapamil and Amentoflavone were 
used alone or in binary combinations in different concentrations. 
• Bidirectional transport was studied and the used compounds were quantified by 
HPLC. 
• The system of differential equations of the mathematical model was fitted to 
experimental concentration data, and optimal values of the kinetic parameters were 
deduced using the software EASY-FIT (Prof. K. Schittkowski, University of 
Bayreuth, Germany). 
Conventional Papp approach and Efflux Ratio
• Initial drug amount in the donor
• Linear drug transport with time applicable to early time points only

























• Some substrates with high passive permeability (e.g. Verapamil) may not be 
detected by this approach
• No separate quantification of the passive permeability and the apical efflux
• No direct quantification of the influence of inhibitors and/or concurrently applied 
compounds
Theoretical modeling: Transport processes considered for modeling 
































































• The change of concentration in the apical, the cellular and the basal compartment is 
considered
• Drug movement between the compartments by passive diffusion through the apical 
and the basal cell membrane is symmetrical and is characterized by the permeability 
coefficient, P
• Drug is subject to carrier mediated active efflux from the cellular to the apical 
compartment. This follows saturable kinetics which may be characterized by the 
kinetic parameters, v
max
, and K, 
• The drug concentration in the apical compartment does not influence efflux 
transport and the entire mass of drug present in the cellular compartment is substrate
of the transporter
• Mass is preserved
differential equations describing the change of drug concentration 
or mass as a function of time in the three compartments during 
permeation in both directions
























































































































Quinidine HCl 80 µM basal to apical
apical  
basal  
passive permeability coefficient of Quinidine 

















Efflux Ratio Quinidine HCl 5 - 100µM


















Passive and carrier-mediated transport of different Quinidine HCl
concentrations in Caco-2 cell monolayers





















Kinetic parameters of transport I
0.2250.0430.210
average Mcell b to a 
[nmol]
0.1440.0041250.137
average Mcell a to b 
[nmol]
1.2811.4382.941vk [pmol/(s•cm2)]





Kinetic parameters of transport II – transport inhibition
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Transport processes considered for modeling drug permeation in 
the Caco-2 monolayer and relevant processes including phase II 











































































total phase II 
metabolism kM
Metabolites
differential equations describing the Amentoflavone transport 
including adsorption and phase II metabolism as a function of time 









































































Amentoflavone 5µM basal to apical
apical
basal























• All compounds used individually showed a polarised transport behaviour, the extent 
of which depended on the drug and the concentration used
• Kinetic parameters of the transport could be calculated with the developed model 
which included passive and carrier mediated transport, metabolism and non-specific 
adsorption
• Model estimated passive permeability coefficient of each drug was independent of 
concentration and varied between the drugs
• Model estimated apical efflux parameters varied between the different drugs and 
expressed the mass efflux rate of these drugs elicited by P-glycorprotein in Caco-2 
cells
• The apical efflux parameter also reflected inhibition of the efflux by concomitant 
drugs  
• Phase II metabolic rate constant in the cell was estimated
• By integrating surface adsorption, cellular transport was corrected for this distorting 
effect
